MARKET

PSNL

PSNL

Personalis
NASDAQ
4.820
-0.320
-6.23%
After Hours: 4.850 +0.03 +0.62% 19:58 05/14 EDT
OPEN
5.14
PREV CLOSE
5.14
HIGH
5.28
LOW
4.800
VOLUME
590.01K
TURNOVER
--
52 WEEK HIGH
7.20
52 WEEK LOW
1.135
MARKET CAP
425.73M
P/E (TTM)
-3.7361
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PSNL last week (0505-0509)?
Weekly Report · 2d ago
Personalis Q1 2025 Earnings: Growth and Strategic Advances
TipRanks · 05/08 00:19
Will Personalis' Testing Growth And MRD Strategy Pay Off In 2025?
NASDAQ · 05/07 15:49
Analyst Expectations For Personalis's Future
Benzinga · 05/07 14:01
Personalis (PSNL) Receives a Buy from Lake Street
TipRanks · 05/07 13:07
Personalis Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/07 12:10
Personalis Price Target Raised to $9.00/Share From $8.00 by HC Wainwright & Co.
Dow Jones · 05/07 12:10
HC Wainwright & Co. Maintains Buy on Personalis, Raises Price Target to $9
Benzinga · 05/07 12:00
More
About PSNL
More
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.
Recently
Symbol
Price
%Change

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.